NeuBase Therapeutics, Inc. (NBSE) Social Stream



NeuBase Therapeutics, Inc. (NBSE): $0.90

0.04 (+4.07%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add NBSE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#83 of 344

in industry

NEUBASE THERAPEUTICS INC (NBSE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NBSE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-13 1 $18 $15 $16.666 $0.742 2146.09%
2022-02-16 2 $18 $15 $16.666 $0.742 2146.09%
2022-05-24 3 $17 $9 $13.666 $0.742 1741.78%
2022-05-31 3 $17 $9 $12 $0.742 1517.25%
2022-08-22 3 $17 $7 $11.333 $0.742 1427.36%
2022-08-26 3 $15 $7 $10.666 $0.742 1337.47%
2022-10-18 2 $20.02 $20.02 $20.02 $0.742 2598.11%
NA 1 $NA $NA $NA $0.742 NA%

The Trend in the Analyst Price Target


NBSE's average price target has moved down $15.67 over the prior 41 weeks.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

NBSE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 1 0 3 0 0 4

The Trend in the Broker Recommendations


Over the past 22 months, NBSE's average broker recommendation rating worsened by 1.6.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how NEUBASE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 91.42% of that group.
  • NBSE has a higher upside potential (average analyst target price relative to current price) than 1240.02% of all US stocks.
  • NBSE has a lower variance in analysts' estimates than -267.3% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, NEUBASE THERAPEUTICS INC's average analyst price target is greater than 296.18% of them.

In the Pharmaceutical Products industry, CYCC, SONN, and SNGX are the three stocks most similar to NEUBASE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for NBSE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!